Search results for " Information asymmetry"
showing 3 items of 3 documents
AgriChain: Blockchain Syntactic and Semantic Validation for Reducing Information Asymmetry In Agri-Food
2022
Information asymmetry affects the actors of all the segments of the agri-food supply chain and can arise many problems in the market along the production chain. Transactions of agri-food products are asymmetric because suppliers and buyers have different levels of knowledge on the provenance, value, quality, and freshness of food. Collusive relations among the agri-food chain actors, especially between controllers companies and controlled ones, can cause market failures as they influence customers’ purchase decisions and severe health accidents when food safety is compromised. This paper proposes using blockchain technology to combat information asymmetry and collusive relations. In additio…
Consumer interest in information regarding novel food technologies in Italy: The case of irradiated foods
2018
Recent food crises and uncertainty regarding food quality have pushed consumers towards a growing need to know more about the foods they purchase, including information related to both food quality and production. This paper identifies the main factors affecting consumer interest in receiving information on food irradiation technology. An online survey was used for research purposes and a total of 392 people, living in Italy, were questioned. Findings revealed that 89.2% of Italian consumers are interested in receiving information on the treatment of foods with ionizing radiation aimed at raising product safety. In particular, this interest was greater for respondents who reported a high se…
Capital structure decisions in the biotechnology industry: the role of R&D collaborations with pharmaceutical incumbents
2011
This study focuses on the importance of collaborative R&D attitudes of biotech firms in the capital structure determination. Specifically, we investigate the short term impact of R&D agreements on financial leverage and we analyze whether this relationship depends on alliances’ features and the type and characteristics of the partners involved. Our results suggest that agreements with established pharmaceutical incumbents are followed by a reduction in the level of debt, while collaborations with biotech firms do not play a significant role, at least in the short term. However, different explanations are plausible. Our findings could be consistent with an “extension” of the pecking order th…